vs
Side-by-side financial comparison of SIRIUS XM HOLDINGS INC. (SIRI) and Steris (STE). Click either name above to swap in a different company.
SIRIUS XM HOLDINGS INC. is the larger business by last-quarter revenue ($2.2B vs $1.5B, roughly 1.5× Steris). Steris runs the higher net margin — 12.9% vs 4.5%, a 8.4% gap on every dollar of revenue. On growth, Steris posted the faster year-over-year revenue change (9.2% vs 0.2%). SIRIUS XM HOLDINGS INC. produced more free cash flow last quarter ($536.0M vs $199.5M). Over the past eight quarters, Steris's revenue compounded faster (15.8% CAGR vs 0.7%).
XM Satellite Radio Holdings Inc. (XM) was one of the three satellite radio (SDARS) and online radio services in the United States and Canada, operated by Sirius XM Holdings. It provided pay-for-service radio, analogous to subscription cable television. Its service included 73 different music channels, 39 news, sports, talk and entertainment channels, 21 regional traffic and weather channels, and 23 play-by-play sports channels. XM channels were identified by Arbitron with the label "XM".
Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.
SIRI vs STE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.2B | $1.5B |
| Net Profit | $99.0M | $192.9M |
| Gross Margin | 53.1% | 43.8% |
| Operating Margin | 10.3% | 18.3% |
| Net Margin | 4.5% | 12.9% |
| Revenue YoY | 0.2% | 9.2% |
| Net Profit YoY | -55.4% | 11.2% |
| EPS (diluted) | $0.23 | $1.96 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.2B | $1.5B | ||
| Q2 25 | $2.1B | $1.4B | ||
| Q1 25 | $2.1B | $1.5B | ||
| Q4 24 | $2.2B | $1.4B | ||
| Q3 24 | $2.2B | $1.3B | ||
| Q2 24 | $2.2B | $1.3B | ||
| Q1 24 | $2.2B | $1.1B |
| Q4 25 | $99.0M | $192.9M | ||
| Q3 25 | $297.0M | $191.9M | ||
| Q2 25 | $205.0M | $177.4M | ||
| Q1 25 | $204.0M | $145.7M | ||
| Q4 24 | $222.0M | $173.5M | ||
| Q3 24 | $-2.5B | $150.0M | ||
| Q2 24 | $304.0M | $145.4M | ||
| Q1 24 | $265.0M | $-1.4M |
| Q4 25 | 53.1% | 43.8% | ||
| Q3 25 | 52.2% | 44.2% | ||
| Q2 25 | 52.4% | 45.1% | ||
| Q1 25 | 52.0% | 43.3% | ||
| Q4 24 | 52.9% | 44.5% | ||
| Q3 24 | 53.2% | 43.6% | ||
| Q2 24 | 53.5% | 44.7% | ||
| Q1 24 | 52.5% | 40.2% |
| Q4 25 | 10.3% | 18.3% | ||
| Q3 25 | 22.8% | 18.2% | ||
| Q2 25 | 17.1% | 17.7% | ||
| Q1 25 | 18.7% | 14.6% | ||
| Q4 24 | 20.2% | 17.9% | ||
| Q3 24 | -133.6% | 16.5% | ||
| Q2 24 | 23.2% | 14.5% | ||
| Q1 24 | 20.2% | 22.0% |
| Q4 25 | 4.5% | 12.9% | ||
| Q3 25 | 13.8% | 13.1% | ||
| Q2 25 | 9.6% | 12.8% | ||
| Q1 25 | 9.9% | 9.8% | ||
| Q4 24 | 10.1% | 12.7% | ||
| Q3 24 | -113.1% | 11.3% | ||
| Q2 24 | 14.0% | 11.4% | ||
| Q1 24 | 12.3% | -0.1% |
| Q4 25 | $0.23 | $1.96 | ||
| Q3 25 | $0.84 | $1.94 | ||
| Q2 25 | $0.57 | $1.79 | ||
| Q1 25 | $0.59 | $1.48 | ||
| Q4 24 | $2.45 | $1.75 | ||
| Q3 24 | $-8.74 | $1.51 | ||
| Q2 24 | $0.08 | $1.46 | ||
| Q1 24 | $0.07 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $94.0M | $423.7M |
| Total DebtLower is stronger | $8.6B | $1.9B |
| Stockholders' EquityBook value | $11.6B | $7.2B |
| Total Assets | $27.2B | $10.6B |
| Debt / EquityLower = less leverage | 0.75× | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $94.0M | $423.7M | ||
| Q3 25 | $79.0M | $319.2M | ||
| Q2 25 | $92.0M | $279.7M | ||
| Q1 25 | $127.0M | $171.7M | ||
| Q4 24 | $162.0M | $155.2M | ||
| Q3 24 | $127.0M | $172.2M | ||
| Q2 24 | $100.0M | $198.3M | ||
| Q1 24 | $71.0M | $207.0M |
| Q4 25 | $8.6B | $1.9B | ||
| Q3 25 | $9.0B | $1.9B | ||
| Q2 25 | $10.1B | $1.9B | ||
| Q1 25 | $10.4B | $1.9B | ||
| Q4 24 | $10.3B | $2.0B | ||
| Q3 24 | $10.1B | $2.2B | ||
| Q2 24 | $9.0B | $2.2B | ||
| Q1 24 | $8.7B | $3.1B |
| Q4 25 | $11.6B | $7.2B | ||
| Q3 25 | $11.6B | $7.0B | ||
| Q2 25 | $11.3B | $7.0B | ||
| Q1 25 | $11.2B | $6.6B | ||
| Q4 24 | $11.1B | $6.4B | ||
| Q3 24 | $10.9B | $6.6B | ||
| Q2 24 | $-2.1B | $6.4B | ||
| Q1 24 | $-2.4B | $6.3B |
| Q4 25 | $27.2B | $10.6B | ||
| Q3 25 | $27.4B | $10.4B | ||
| Q2 25 | $27.3B | $10.4B | ||
| Q1 25 | $27.4B | $10.1B | ||
| Q4 24 | $27.5B | $10.0B | ||
| Q3 24 | $27.5B | $10.2B | ||
| Q2 24 | $11.2B | $10.1B | ||
| Q1 24 | $11.2B | $11.1B |
| Q4 25 | 0.75× | 0.27× | ||
| Q3 25 | 0.78× | 0.27× | ||
| Q2 25 | 0.89× | 0.27× | ||
| Q1 25 | 0.93× | 0.29× | ||
| Q4 24 | 0.93× | 0.32× | ||
| Q3 24 | 0.93× | 0.33× | ||
| Q2 24 | — | 0.35× | ||
| Q1 24 | — | 0.50× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $680.0M | $298.2M |
| Free Cash FlowOCF − Capex | $536.0M | $199.5M |
| FCF MarginFCF / Revenue | 24.4% | 13.3% |
| Capex IntensityCapex / Revenue | 6.6% | 6.6% |
| Cash ConversionOCF / Net Profit | 6.87× | 1.55× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2B | $917.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $680.0M | $298.2M | ||
| Q3 25 | $430.0M | $287.8M | ||
| Q2 25 | $546.0M | $420.0M | ||
| Q1 25 | $242.0M | $260.8M | ||
| Q4 24 | $679.0M | $332.8M | ||
| Q3 24 | $240.0M | $250.7M | ||
| Q2 24 | $514.0M | $303.7M | ||
| Q1 24 | $308.0M | $254.8M |
| Q4 25 | $536.0M | $199.5M | ||
| Q3 25 | $255.0M | $201.3M | ||
| Q2 25 | $401.0M | $326.4M | ||
| Q1 25 | $53.0M | $189.9M | ||
| Q4 24 | $514.0M | $243.6M | ||
| Q3 24 | $24.0M | $148.8M | ||
| Q2 24 | $341.0M | $195.7M | ||
| Q1 24 | $134.0M | $163.3M |
| Q4 25 | 24.4% | 13.3% | ||
| Q3 25 | 11.8% | 13.8% | ||
| Q2 25 | 18.8% | 23.5% | ||
| Q1 25 | 2.6% | 12.8% | ||
| Q4 24 | 23.5% | 17.8% | ||
| Q3 24 | 1.1% | 11.2% | ||
| Q2 24 | 15.7% | 15.3% | ||
| Q1 24 | 6.2% | 14.6% |
| Q4 25 | 6.6% | 6.6% | ||
| Q3 25 | 8.1% | 5.9% | ||
| Q2 25 | 6.8% | 6.7% | ||
| Q1 25 | 9.1% | 4.8% | ||
| Q4 24 | 7.5% | 6.5% | ||
| Q3 24 | 9.9% | 7.7% | ||
| Q2 24 | 7.9% | 8.4% | ||
| Q1 24 | 8.0% | 8.2% |
| Q4 25 | 6.87× | 1.55× | ||
| Q3 25 | 1.45× | 1.50× | ||
| Q2 25 | 2.66× | 2.37× | ||
| Q1 25 | 1.19× | 1.79× | ||
| Q4 24 | 3.06× | 1.92× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | 1.69× | 2.09× | ||
| Q1 24 | 1.16× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SIRI
| Subscription And Circulation | $1.6B | 74% |
| Advertising | $491.0M | 22% |
| Cost Of Sales Equipment Products And Services | $48.0M | 2% |
| Other Revenue | $28.0M | 1% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
